Alexion Pharmaceuticals – ALXN
Alexion ALXN Pharmaceuticals rallied with the broad market Thursday and is now 2% past a 118.39 buy point. It’s in buying range, but the breakout has had a hard time getting going, which isn’t the best of signs. After the Oct. 25 breakout, Alexion erased a 7% gain but found its footing at the 50-day… Read More »